JohnGordanMD

Myeloproliferative Disorder Hematology-Oncology

Physician

Dr. Gordan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1001 Sneath Ln
San Bruno, CA 94066
Phone+1 650-615-6000

Fax+1 650-615-6015

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2011 - 2014
University of California (San Francisco)Residency, Internal Medicine, 2009 - 2011
Perelman School of Medicine at the University of PennsylvaniaClass of 2009

PubMed

Human GM-CSF/IL-3 enhance tumor immune infiltration in humanized HCC patient-derived xenografts.
Kelley Weinfurtner, David Tischfield, George McClung, Jennifer Crainic, John Gordan
JHEP Reports. 2025-03-01
HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma.
Rigney E Turnham, Adriana Pitea, Gwendolyn M Jang, Zhong Xu, Huat Chye Lim
Cancer Research. 2025-02-17
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming.
Ilaria Gritti, Jinkai Wan, Vajira Weeresekara, Joel M Vaz, Giuseppe Tarantino
Cancer Discovery. 2025-02-07

Journal Articles

Overexpression-Mediated Activation of MET in the Golgi Promotes HER3/ERBB3 Phosphorylation
John Gordan, MD, Nature
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma
John D Gordan, Xin Chen, Clinical Cancer Research

Drug Hobbles Deadly Liver Cancer by Stifling Protein ProductionJanuary 14th, 2019
OncLive® Hosts State of the Science Summit™: Gastrointestinal MalignanciesFebruary 22nd, 2018
John Gordan of UCSF Discusses His Work in Fibrolamellar CarcinomaNovember 13th, 2017